| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/08/2007 | CN101012224A Quinoline derivative, preparation method and medical use thereof |
| 08/08/2007 | CN101012221A Antineoplastic alkaloid |
| 08/08/2007 | CN101012213A Derivative of genistein and its preparing method and use |
| 08/08/2007 | CN101012210A Taxone derivatives, preparing method and pharmaceutical use thereof |
| 08/08/2007 | CN101012196A Fragrant geldanamycin derivative and its preparing method and use |
| 08/08/2007 | CN101012191A Compound for generating nucleic acid cross-linking action by induction and its preparing method and use |
| 08/08/2007 | CN101011579A Application of cytoplasm-targeting chitosan oligosaccharide-aliphatic acid grafting medicinal-vector colloidal cluster |
| 08/08/2007 | CN101011577A Polyamide dendroid polymer nano particle loading survivin small molecule RNA |
| 08/08/2007 | CN101011576A Compositions and methods for treating or preventing inflammatory diseases |
| 08/08/2007 | CN101011574A Use of an anti-il6 receptor antibody for preparing pharmaceutical composition |
| 08/08/2007 | CN101011573A Production of high molecular mass lectins |
| 08/08/2007 | CN101011571A Use of GADD45 beta protein and its inhibitor in treatment of rheumatoid arthritis |
| 08/08/2007 | CN101011559A Traditional Chinese medicine preparation for treating malignant tumor and its preparation method |
| 08/08/2007 | CN101011558A Antineoplastic, anti-cancer drugs |
| 08/08/2007 | CN101011543A Antineoplastic medicine composition |
| 08/08/2007 | CN101011520A Method for preparing medicament containing trillium tschonoskii extractive and its application |
| 08/08/2007 | CN101011512A Medicine for treating digestive tract tumour and its preparing process |
| 08/08/2007 | CN101011499A Linaloe leaf extract, pharmaceutical and health care uses thereof |
| 08/08/2007 | CN101011464A Composite propolis soft capsule |
| 08/08/2007 | CN101011449A Method for preparing purple sweet potato granule |
| 08/08/2007 | CN101011438A Use of asafetida in the process for preparing anti-cancer medicament |
| 08/08/2007 | CN101011426A Medicated wine for treating cancer and preparing process thereof |
| 08/08/2007 | CN101011425A Traditional Chinese medicine for treating esophagus cancer, gastric cancer, uterocarcinoma and hysteromyoma |
| 08/08/2007 | CN101011423A Traditional Chinese medicine for treating tumor |
| 08/08/2007 | CN101011420A Preparing process and usage of grease of housefly larva and fatty acid thereof |
| 08/08/2007 | CN101011419A Bee glue preparation and its preparation method |
| 08/08/2007 | CN101011404A Use of caudatin-3-O-beta-D-cymaroside as medicament for treating tumour |
| 08/08/2007 | CN101011399A Use of tetrandrine as chemotherapy pharmaceutical sensitivity agent for treating gastric cancer |
| 08/08/2007 | CN101011380A Use of taspine for preparing medicament for inhibiting tumor angiogenesis |
| 08/08/2007 | CN101011377A Application of compound s6 in the process for preparing anti-cancer medicament |
| 08/08/2007 | CN101011376A Self-emulsifying capsule of docetaxel and its preparation method |
| 08/08/2007 | CN101011359A Solid liposome nano granule with antineoplastic activity |
| 08/08/2007 | CN101011358A Nanostructured liposome vector with highly effective antineoplastic activity |
| 08/08/2007 | CN101011357A Process for preparing Paclitaxel liposome preparation |
| 08/08/2007 | CN101011355A Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof |
| 08/08/2007 | CN101011353A Anti-cancer composition loading both platinum compound and alkylating agent |
| 08/08/2007 | CN101011352A Anti-cancer composition loading both mtrosourea medicament and guanopterin analog |
| 08/08/2007 | CN101011351A Anti-cancer composition loading both platinum compound and synergist |
| 08/08/2007 | CN101011350A Anti solid tumor composition |
| 08/08/2007 | CN101011349A Slow release injection containing mtrosourea medicament and topoisomerase inhibitor |
| 08/08/2007 | CN101011348A Anti-cancer composition loading both mtrosourea medicament and alkaloids medicament |
| 08/08/2007 | CN101011347A Slow release injection containing platinum compound and topoisomerase inhibitor |
| 08/08/2007 | CN101011346A Anti-cancer composition loading both mtrosourea medicament and synergist |
| 08/08/2007 | CN101011345A Slow release injection containing platinum compound and alkylating agent |
| 08/08/2007 | CN101011344A Anti-cancer composition loading both mtrosourea medicament and alkylating agent |
| 08/08/2007 | CN101011343A Slow release injection containing anti-metabolism medicament and alkylating agent |
| 08/08/2007 | CN101011342A Slow release injection containing anti-metabolism medicament and platinum compound |
| 08/08/2007 | CN101011341A Slow release injection containing anti-metabolism medicament and topoisomerase inhibitor |
| 08/08/2007 | CN101011340A Anti-cancer composition loading both anti-metabolism medicament and alkylating agent |
| 08/08/2007 | CN101011157A Food additive and producing process thereof |
| 08/08/2007 | CN101011151A Health care bamboo salt and its preparing method |
| 08/08/2007 | CN101011145A Edible Collybia albuminosa(Berk.) Petch stuffing |
| 08/08/2007 | CN101011094A Waxberry tea and its preparation method |
| 08/07/2007 | US7253294 Saponifying green plant oleoresin to provide a saponified resin, adding a first volatile organic solvent to provide a suspension, removing the solids, condensing the solution to provide an oil; and adding a second volatile organic solvent to solidify the natural product |
| 08/07/2007 | US7253286 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective |
| 08/07/2007 | US7253270 Polynucleotide encoding a mutated HIV gp41 polypeptide |
| 08/07/2007 | US7253263 Complementarity determining region-grafted antibody against ganglioside GD3 and derivative of antibody against ganglioside GD3 |
| 08/07/2007 | US7253254 Polypeptide variants with increased heparin-binding capacity |
| 08/07/2007 | US7253209 Dissolving in iodinated poppyseed oil fatty ester |
| 08/07/2007 | US7253203 Indoline derivatives |
| 08/07/2007 | US7253199 Azole derivatives and pharmaceutical compositions containing them |
| 08/07/2007 | US7253194 Compounds and inhibitors of phospholipases |
| 08/07/2007 | US7253191 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry |
| 08/07/2007 | US7253189 1-aminoindane derivatives, e.g., 1-(cyclopentylcarbonylamino)-5-(4-cyclopropyl-2-(phenylsulfonyl)phenylsulfonyl)indane; exhibit anti-inflammatory and immunomodulatory activity |
| 08/07/2007 | US7253187 Heterocyclic inhibitors of ERK2 and uses thereof |
| 08/07/2007 | US7253184 4-Phenoxyanilino-substituted; inhibitors of specific kinase enzymes, such as MEK enzymes |
| 08/07/2007 | US7253174 (Anilino)(halo)pyrimidine derivatives or (anilino)(amino)pyrimidine derivatives; treating rheumatoid arthritis, psoriasis, Crohn's Disease, osteoarthritis or osteoporosis. |
| 08/07/2007 | US7253172 Enzyme inhibitor for treating a non-insulin dependent diabetes mellitus; 3-Amino-4-(3,4-difluorophenyl)butanoyl]-4-[2-({3-[(methylsulfonyl)amino]-phenyl}-amino)-2-oxoethyl]piperazin-2-yl}acetic acid |
| 08/07/2007 | US7253171 Antiinflammatory agents; immunology diseases; multiple sclerosis; antihistamines; antidiabetic agents; vision defects; antiarthritic agents; skin disorders; antitumor agents |
| 08/07/2007 | US7253158 Sulfonamides |
| 08/07/2007 | US7253151 Genes of IL-12P40 subunit mutated for improving the activity of IL-12 and use thereof for DNA vaccine adjuvant |
| 08/07/2007 | US7253146 Biopolymer compounds for prevention and treatment of cell proliferative, respiratory system, viral and microbial disorders; antitumor/antiprolifefrative agents; disenfectants |
| 08/07/2007 | US7253143 For treatment of urinary tract infections and inflammations, colitis, and candida infections of mucosal membranes; infant formula food containing the peptide |
| 08/07/2007 | US7252996 Ancillary composition for the preparation of committed mature dentritic cells |
| 08/07/2007 | US7252994 Human DR4 antibodies and uses thereof |
| 08/07/2007 | US7252838 Ligating band also may include an inner diffusion barrier disposed between the elastomeric layer and the inner drug releasing layer |
| 08/07/2007 | US7252825 MAGE-3 peptides presented by HLA class II molecules |
| 08/07/2007 | US7252824 Anti-neovasculature preparations for cancer |
| 08/07/2007 | US7252817 Administering viruses selected from modified adenovirus, modified HSV, modified vaccinia virus and modified parapoxvirus to mammal having Ras-activated pathway to result in lysis of proliferating cells |
| 08/07/2007 | US7252815 using carbocyanine dye; photodynamic therapy; supplying to tumor |
| 08/07/2007 | US7252799 Methods for sterilizing preparations containing albumin |
| 08/07/2007 | CA2470124C Process for preparing 10-desacetylbaccatine iii |
| 08/07/2007 | CA2381770C Human ctla-4 antibodies and their uses |
| 08/07/2007 | CA2376379C Modified chimeric polypeptides with improved pharmacokinetic properties |
| 08/07/2007 | CA2340636C Combinations of tetracyclic cyclic gmp-specific phosphodiesterase inhibitors with further therapeutic agents |
| 08/07/2007 | CA2332007C Adenosine a3 receptor modulators |
| 08/07/2007 | CA2317589C Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 08/07/2007 | CA2286304C Pca3, pca3 genes, and methods of use |
| 08/07/2007 | CA2246378C Isolation and use of sh3 binding peptides |
| 08/07/2007 | CA2192360C Bicyclic lactam inhibitor of interleukin-1-beta converting enzyme |
| 08/07/2007 | CA2182388C Process for producing endotoxin-free or endotoxin-poor nucleic acids and/or oligonucleotides for gene therapy |
| 08/02/2007 | WO2007087419A2 Substituted 3-(5-membered unsaturated heterocyclyl) -1, 3-dihydro-indol-2-one derivatives as tyrosine kinase inhibitors for the treatment of cancer |
| 08/02/2007 | WO2007087395A2 UNSATURATED mTOR INHIBITORS |
| 08/02/2007 | WO2007087276A1 Aurora kinase modulators and method of use |
| 08/02/2007 | WO2007087026A2 Solid-state form of amg 706 and pharmaceutical compositions thereof |
| 08/02/2007 | WO2007086932A2 Prostate stem cell antigen vaccines and uses thereof |
| 08/02/2007 | WO2007086651A1 Anti-cancer agent loaded hydrophobic bile acid conjugated hydrophilic chitosan oligosaccharide nanoparticles and preparation method thereof |
| 08/02/2007 | WO2007086545A1 Method for screening cell function regulator |
| 08/02/2007 | WO2007086526A1 Gene polymorphism and use thereof |
| 08/02/2007 | WO2007086395A1 Photodynamic therapy kit |